0
Editorials |

Physician Education and the Pharmaceutical Industry

Robert G. Johnson, MD, FCCP
Author and Funding Information

Affiliations: Northbrook, IL 
 ,  Dr. Johnson is Chairman and C. Rollins Hanlon Professor of Surgery at St. Louis University, St. Louis, MO, and President of the American College of Chest Physicians, Northbrook, IL.

Correspondence to: Robert G. Johnson, MD, FCCP, St. Louis University, Department of Surgery, Desloge Tower, 3rd Floor, 3635 Vista-Grand Ave, St. Louis, MO 63110; e-mail:johnsorg@slu.edu



Chest. 2001;119(4):995-996. doi:10.1378/chest.119.4.995
Text Size: A A A
Published online

Extract

In the current issue of CHEST (see pages 1255 and 1257), two thoughtful leaders of the American College of Chest Physicians (ACCP) frame an issue that confronts most physicians today—the relationship between us, the physicians, and the medical products industry. This relationship connects those who sell medical products (pharmaceutical or technology) and those who prescribe the use of those products (we, the physicians). More specifically, the comments written by Basil Varkey, MD, FCCP, and Alvin Lever, MA, FCCP (Hon), address the role of the pharmaceutical industry in physician education. This is an intellectual, civil exchange between two individuals who are united in their support of the ACCP: Dr. Varkey, a longtime ACCP Fellow, and Mr. Lever, the Executive Vice President and Chief Executive Officer (CEO) of the organization.

First Page Preview

View Large
First page PDF preview

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
COPD in 2001*: A Major Challenge for Medicine, the Pharmaceutical Industry, and Society
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543